As geopolitical tensions push oil prices higher and inflation concerns resurface, the Canadian market faces renewed scrutiny over interest rates and economic resilience. In this environment, growth companies with high insider ownership can be particularly appealing, as they often signal strong internal confidence and alignment with shareholder interests.
| Name | Insider Ownership | Earnings Growth |
| Sernova Biotherapeutics (TSX:SVA) | 13.5% | 60.9% |
| ROK Resources (TSXV:ROK) | 17.7% | 87.4% |
| Propel Holdings (TSX:PRL) | 28.0% | 37.1% |
| Heliostar Metals (TSXV:HSTR) | 16.2% | 20.7% |
| Hammond Power Solutions (TSX:HPS.A) | 27.2% | 28.2% |
| Electrovaya (TSX:ELVA) | 35.2% | 42% |
| Cizzle Brands (NEOE:CZZL) | 13.1% | 90.4% |
| CEMATRIX (TSX:CEMX) | 10.7% | 44.9% |
| Cambria Gold Mines (TSXV:CAMB) | 13.7% | 87.7% |
| Aritzia (TSX:ATZ) | 16.3% | 20.3% |
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Anaergia Inc., along with its subsidiaries, operates in Italy, North America, Europe, the Middle East and Africa, and the Asia Pacific, offering solutions for renewable energy generation and waste-to-resource conversion; it has a market cap of CA$410.42 million.
Operations: Anaergia's revenue is derived from three main segments: O&M Services contributing CA$19.36 million, Capital Sales at CA$178.52 million, and Build, Own, and Operate generating CA$12.66 million.
Insider Ownership: 26.1%
Revenue Growth Forecast: 20.3% p.a.
Anaergia is poised for growth with a forecasted 20.3% annual revenue increase, outpacing the Canadian market. Analysts expect the stock price to rise significantly, though recent insider selling raises some concerns. The company is enhancing its renewable energy projects, such as a CAD 14 million contract in Australia and delivering renewable natural gas in California. Despite current losses, Anaergia aims for profitability within three years, supported by strategic financial arrangements like its CAD 20 million credit facility.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada with a market cap of CA$451.46 million.
Operations: The company generates revenue of CA$213.33 million from the sale of eyewear products across its digital platform in the United States and Canada.
Insider Ownership: 25.8%
Revenue Growth Forecast: 14.5% p.a.
Kits Eyecare is positioned for growth with revenue expected to increase by 14.5% annually, outpacing the Canadian market. Despite some insider selling recently, the company has initiated a share repurchase program to enhance long-term shareholder value. First-quarter sales rose to C$57.47 million from C$46.6 million a year ago, and earnings are forecasted to grow significantly at 51.1% per year, indicating strong potential for future profitability despite current margin pressures.
Simply Wall St Growth Rating: ★★★★★☆
Overview: VersaBank offers a range of banking products and services in Canada and the United States, with a market cap of CA$897.94 million.
Operations: The company's revenue segments include Digital Meteor at CA$2.57 million, Digital Banking USA at CA$23.12 million, Digital Banking Canada at CA$106.25 million, and DRTC services at CA$7.29 million.
Insider Ownership: 11%
Revenue Growth Forecast: 27.5% p.a.
VersaBank's growth trajectory is bolstered by its innovative Real-Time Structured Receivable Program, now expanded to the U.S. market. Recent earnings show net interest income of C$35.68 million for Q2 2026, up from C$28.03 million a year ago, though net income slightly declined to C$7.53 million from C$8.53 million. Revenue and earnings are forecasted to grow significantly at 27.5% and 62.8% annually, respectively, outpacing the Canadian market despite recent insider selling activity.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com